Funded Research
About Funded Research
The MRF has funded millions of dollars in melanoma research since 1998. Our research grants support the study of melanoma prevention, diagnosis, and treatment across the spectrum of the disease, including cutaneous, ocular, and mucosal melanoma. The MRF Research Program supports research across their entire career- from medical students to established investigators. The types of grants supported include:
Peer Reviewed SAC/BC/OM Grants
- Team Awards (established in 2014) – Two-year awards, up to $250,000 per year
- Established (Senior) Investigator Awards (established in 2006) – Two-year awards, up to $100,000 per year
- Career Development (Junior) Awards (established in 1998) – Two-year awards, up to $50,000 per year
- Medical Student Awards (established in 2011) – One-year awards, up to $3,000
Research Awards
- Society for Melanoma Research Young Investigator Awards (sponsored by the MRF since 2013) – One-year awards, $5,000 per year
- Society for Melanoma Research Christopher J. Marshall Award (sponsored by the MRF since 2015) – One-year awards, $5,000 per year
- Donor-directed – donor awards to fund specific areas of melanoma research
Occasionally, we also have special opportunities available that do not adhere to our usual categories.
Filter by State, Melanoma Type, Year, and Grant Category
State
Melanoma Type
Year
Grant Category
2020 Research Grants
Shruthy Suresh, PhD
Memorial Sloan Kettering Cancer Center
2021 Research Grants
Didem Cobanoglu, PhD
Control of Anti-Tumor Response by the Modulation of Neurotransmitter-Expressing Immune Cells
Nathaniel Oberholtzer
Harnessing the antioxidant properties of thioredoxin to enhance tumor-specific T cell memory response in adoptive cell therapy
Eric Grewal
Formulation and Preclinical Testing of an HLA-Engineered Neoantigen Vaccine for Melanoma
Michael Chang
Clinical and genetic predictors of skin toxicity in mucosal melanoma treated with immune checkpoint inhibitors
2020 Research Grants
Diwakar Davar, MD
Integrative Analysis of Prognostic Factors to Neoadjuvant Nivolumab/CMP-001 in Stage III B/C/D Melanoma
Linda Malkas, PhD
Novel Target for Melanoma Therapeutic Development
Thorsten Mempel, MD, PhD
Converting Regulatory into Proinflammatory Anti-Tumor Effector T Cells
Jeffrey Ravetch, MD, PhD
Defining the Mechanisms of Resistance to Anti-CTLA4 Antibodies in the TME
2019 Research Grants
Genevieve Boland, MD, PhD
Characterizing the Role of the Hippo Pathway During Melanoma Immunotherapy
William Sellers, MD
The Development and Characterization of Cellular Models of Uveal Melanoma
J. William Harbour, MD
Cellular and Genomic Landscape of Uveal Melanoma at Single Cell Resolution
Donald McDonnell, PhD
Pharmacological Targeting of Estrogen Receptor to Enhance Melanoma Immunity
2018 Research Grants
A. Hunter Shain, PhD
Society for Melanoma Research Young Investigator Award
Vito Rebecca, PhD
Society for Melanoma Research Christopher J. Marshall Award
Walter Fast, PhD
Innovative Approaches for GNAQ/11 Mutant Characterization and Therapeutic Targeting
Alison Skalet, MD, PhD
A Novel Peripheral Blood Biomarker for Early Diagnosis of Uveal Melanoma
2017 Research Grants
Douglas B. Johnson, MD
Comprehensive Profiling of Immune Checkpoint Inhibitor Colitis
Alan Shain, PhD
The genetic evolution of uveal melanoma
Rizwan Haq, MD, PhD
Targeting genomic mechanisms of resistance to immunotherapy
Joseph Barbi, PhD
Exploring neuritin-mediated immune suppression to improve melanoma therapy